ClinicalTrials.govpublic full text
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
hiv infections, didanosine, dose-response relationship, drug, drug therapy, combination, stavudine, hiv protease inhibitors, reverse transcriptase inhibitors, anti-hiv agents, nelfinavir, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 969920
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.